Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 7, 2007 - Issue 4
Submit an article Journal homepage
457
Views
65
CrossRef citations to date
0
Altmetric
Drug Evaluation

PANVAC™-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma

Ravi A Madan Director, Clinical Immunotherapy Group, National Cancer Institute (NCI), Laboratory of Tumor Immunology and Biology, National Institutes of Health (NIH), 10 Center Drive, Bethesda, MD 20892, USA. [email protected]
,
Philip M Arlen Director, Clinical Immunotherapy Group, National Cancer Institute (NCI), Laboratory of Tumor Immunology and Biology, National Institutes of Health (NIH), 10 Center Drive, Bethesda, MD 20892, USA. [email protected]
&
James L Gulley Director, Clinical Immunotherapy Group, National Cancer Institute (NCI), Laboratory of Tumor Immunology and Biology, National Institutes of Health (NIH), 10 Center Drive, Bethesda, MD 20892, USA. [email protected]
Pages 543-554 | Published online: 21 Mar 2007

Citations (65)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Mohamad Moussa, Athanasios G Papatsoris, Athanasios Dellis, Mohamed Abou Chakra & Wajih Saad. (2020) Novel anticancer therapy in BCG unresponsive non-muscle-invasive bladder cancer. Expert Review of Anticancer Therapy 20:11, pages 965-983.
Read now
Jennifer Tse, Nirmish Singla, Rashed Ghandour, Yair Lotan & Vitaly Margulis. (2019) Current advances in BCG-unresponsive non-muscle invasive bladder cancer. Expert Opinion on Investigational Drugs 28:9, pages 757-770.
Read now
Antonela S. Asad, Mariela A. Moreno Ayala, M. Florencia Gottardo, Camila Zuccato, Alejandro Javier Nicola Candia, Flavia A. Zanetti, Adriana Seilicovich & Marianela Candolfi. (2017) Viral gene therapy for breast cancer: progress and challenges. Expert Opinion on Biological Therapy 17:8, pages 945-959.
Read now
Mariela A. Moreno Ayala, Maria Florencia Gottardo, Antonela S. Asad, Camila Zuccato, Alejandro Nicola, Adriana Seilicovich & Marianela Candolfi. (2017) Immunotherapy for the treatment of breast cancer. Expert Opinion on Biological Therapy 17:7, pages 797-812.
Read now
John Berry, Timothy Vreeland, Alfred Trappey, Diane Hale, Kaitlin Peace, Joshua Tyler, Avery Walker, Ramon Brown, Garth Herbert, Fia Yi, Doreen Jackson, Guy Clifton & George E. Peoples. (2017) Cancer vaccines in colon and rectal cancer over the last decade: lessons learned and future directions. Expert Review of Clinical Immunology 13:3, pages 235-245.
Read now
Andrea Milani, Dario Sangiolo, Massimo Aglietta & Giorgio Valabrega. (2014) Recent advances in the development of breast cancer vaccines. Breast Cancer: Targets and Therapy 6, pages 159-168.
Read now
Ira Surolia, James Gulley & Ravi A Madan. (2014) Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies. Expert Opinion on Biological Therapy 14:12, pages 1769-1781.
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Isabelle Cremer, Jan Henrik ter Meulen, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:6.
Read now
Sofia R Gameiro, Momodou L Jammeh & James W Hodge. (2013) Cancer vaccines targeting carcinoembryonic antigen: state-of-the-art and future promise. Expert Review of Vaccines 12:6, pages 617-629.
Read now
Joseph W Kim & James L Gulley. (2012) Poxviral vectors for cancer immunotherapy. Expert Opinion on Biological Therapy 12:4, pages 463-478.
Read now
Janet Plate. (2011) Clinical trials of vaccines for immunotherapy in pancreatic cancer. Expert Review of Vaccines 10:6, pages 825-836.
Read now
Choon-Kit Tang, Maria Katsara & Vasso Apostolopoulos. (2008) Strategies used for MUC1 immunotherapy: human clinical studies. Expert Review of Vaccines 7:7, pages 963-975.
Read now
Liu Hong & Daiming Fan. (2008) Cancer mucosa antigens: novel immunotherapeutic targets. Expert Opinion on Therapeutic Targets 12:6, pages 749-756.
Read now

Articles from other publishers (52)

Tarak Chouari, Francesca Soraya La Costa, Nabeel Merali, Maria-Danae Jessel, Shivan Sivakumar, Nicola Annels & Adam E. Frampton. (2023) Advances in Immunotherapeutics in Pancreatic Ductal Adenocarcinoma. Cancers 15:17, pages 4265.
Crossref
Kenneth Lundstrom. (2023) Gene Therapy Cargoes Based on Viral Vector Delivery. Current Gene Therapy 23:2, pages 111-134.
Crossref
Hossein Javid, Fatemeh Attarian, Toktam Saadatmand, Nastaran Rezagholinejad, Ali Mehri, Hamed Amiri & Mehdi Karimi‐Shahri. (2023) The therapeutic potential of immunotherapy in the treatment of breast cancer: Rational strategies and recent progress. Journal of Cellular Biochemistry 124:4, pages 477-494.
Crossref
Anurag Kumar Srivastava, Giorgia Guadagnin, Paola Cappello & Francesco Novelli. (2022) Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies. Cancers 15:1, pages 138.
Crossref
Madhu Gupta, Abhishek Wahi, Priyanka Sharma, Riya Nagpal, Neha Raina, Monika Kaurav, Jaydeep Bhattacharya, Sonia M. Rodrigues Oliveira, Karma G. Dolma, Alok K. Paul, Maria de Lourdes Pereira, Polrat Wilairatana, Mohammed Rahmatullah & Veeranoot Nissapatorn. (2022) Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects. Vaccines 10:12, pages 2011.
Crossref
Xinzi Hu, Guangzhi Li & Song Wu. (2022) Advances in Diagnosis and Therapy for Bladder Cancer. Cancers 14:13, pages 3181.
Crossref
Kavita Singh, Dhananjay Yadav, Meenu Jain, Pramod Kumar Singh & Jun-O Jin. (2022) Immunotherapy for Breast Cancer Treatment: Current Evidence and Therapeutic Options. Endocrine, Metabolic & Immune Disorders - Drug Targets 22:2, pages 212-224.
Crossref
Susanne Deininger, Peter Törzsök, Michael Mitterberger, Maximilian Pallauf, David Oswald, Christian Deininger & Lukas Lusuardi. (2022) From Interferon to Checkpoint Inhibition Therapy—A Systematic Review of New Immune-Modulating Agents in Bacillus Calmette–Guérin (BCG) Refractory Non-Muscle-Invasive Bladder Cancer (NMIBC). Cancers 14:3, pages 694.
Crossref
Kenneth Lundstrom. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity 763 776 .
Kenneth Lundstrom. 2022. The Biological Role of a Virus. The Biological Role of a Virus 285 341 .
Aaron T. Ciner, Keaton Jones, Ruth J. Muschel & Pnina Brodt. (2021) The unique immune microenvironment of liver metastases: Challenges and opportunities. Seminars in Cancer Biology 71, pages 143-156.
Crossref
Lee A. Hugar, Scott M. Gilbert, Wade J. Sexton, Ashish M. Kamat & Roger Li. (2021) Immunotherapy in Bacillus Calmette–Guerin (BCG) unresponsive nonmuscle invasive bladder cancer. Current Opinion in Urology 31:2, pages 160-169.
Crossref
Stefania Cuzzubbo, Sara Mangsbo, Divya Nagarajan, Kinana Habra, Alan Graham Pockley & Stephanie E. B. McArdle. (2021) Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments. Frontiers in Immunology 11.
Crossref
Hoyoung M. Maeng & Jay A. Berzofsky. 2021. Principles of Translational Science in Medicine. Principles of Translational Science in Medicine 307 328 .
Altijana Hromic-Jahjefendic & Kenneth Lundstrom. (2020) Viral Vector-Based Melanoma Gene Therapy. Biomedicines 8:3, pages 60.
Crossref
David Repáraz, Diana Llopiz & Pablo Sarobe. (2019) When Cancer Vaccines Go Viral. Clinical Cancer Research 25:16, pages 4871-4873.
Crossref
Hoyoung M. Maeng & Jay A. Berzofsky. (2019) Strategies for developing and optimizing cancer vaccines. F1000Research 8, pages 654.
Crossref
Kenneth Lundstrom. (2018) Viral Vectors in Gene Therapy. Diseases 6:2, pages 42.
Crossref
Venkatesh Krishnan, Jonathan S. Berek & Oliver Dorigo. (2017) Immunotherapy in ovarian cancer. Current Problems in Cancer 41:1, pages 48-63.
Crossref
Chris Heery, Anteneh Tesfaye, Benjamin Weinberg & John Marshall. 2017. Immunotherapy for Gastrointestinal Cancer. Immunotherapy for Gastrointestinal Cancer 47 78 .
James W. Hodge, Amanda L. Boehm & Renee N. Donahue. 2017. Cancer Therapeutic Targets. Cancer Therapeutic Targets 67 76 .
Katy J. McCann, Ann Mander, Angelica Cazaly, Lindsey Chudley, Jana Stasakova, Stephen M. Thirdborough, Andrew King, Paul Lloyd-Evans, Emily Buxton, Ceri Edwards, Sarah Halford, Andrew Bateman, Ann O'Callaghan, Sally Clive, Alan Anthoney, Duncan I. Jodrell, Toni Weinschenk, Petra Simon, Ugur Sahin, Gareth J. Thomas, Freda K. Stevenson & Christian H. Ottensmeier. (2016) Targeting Carcinoembryonic Antigen with DNA Vaccination: On-Target Adverse Events Link with Immunologic and Clinical Outcomes. Clinical Cancer Research 22:19, pages 4827-4836.
Crossref
Akhil Muthigi, Arvin K. George, Sam J. Brancato & Piyush K. Agarwal. (2016) Novel immunotherapeutic approaches to the treatment of urothelial carcinoma. Therapeutic Advances in Urology 8:3, pages 203-214.
Crossref
Zahid Delwar, Kaixin Zhang, Paul S. Rennie & William Jia. (2016) Oncolytic virotherapy for urological cancers. Nature Reviews Urology 13:6, pages 334-352.
Crossref
Manzoor M KhanManzoor M. Khan. 2016. Immunopharmacology. Immunopharmacology 363 396 .
Cariad Chester, Oliver Dorigo, Jonathan S Berek & Holbrook Kohrt. (2015) Immunotherapeutic approaches to ovarian cancer treatment. Journal for ImmunoTherapy of Cancer 3:1.
Crossref
Lucas Sánchez-Sampedro, Beatriz Perdiguero, Ernesto Mejías-Pérez, Juan García-Arriaza, Mauro Di Pilato & Mariano Esteban. (2015) The Evolution of Poxvirus Vaccines. Viruses 7:4, pages 1726-1803.
Crossref
Elizabeth A. Mittendorf. (2015) Breast Cancer Vaccines: Injecting Hope. Breast Diseases: A Year Book Quarterly 26:4, pages 279-281.
Crossref
Mauricio Burotto, Nishith Singh, Christopher R. Heery, James L. Gulley & Ravi A. Madan. (2014) Exploiting Synergy: Immune-Based Combinations in the Treatment of Prostate Cancer. Frontiers in Oncology 4.
Crossref
Si-Xue Liu. (2014) Gene therapy in pancreatic cancer. World Journal of Gastroenterology 20:37, pages 13343.
Crossref
Christiaan R. de Vries, Elizabeth Poplin, Robert E. Weiss, David A. August, Emmanuel Gabriel, Robert S. DiPaola & Edmund C. Lattime. 2014. Gene Therapy of Cancer. Gene Therapy of Cancer 241 257 .
Ravi A. Madan, Theresa A. Ferrara & James L. Gulley. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics 553 568 .
Youngjoo ChoiJun Chang. (2013) Viral vectors for vaccine applications. Clinical and Experimental Vaccine Research 2:2, pages 97.
Crossref
Jeffrey Schlom, James W. Hodge, Claudia Palena, John W. Greiner, Kwong-Yok Tsang, Benedetto Farsaci, Ravi A. Madan & James L. Gulley. 2013. Cancer Immunotherapy. Cancer Immunotherapy 309 331 .
James W. Hodge, Amanda L. Boehm & Renee N. Donahue. 2016. Cancer Therapeutic Targets. Cancer Therapeutic Targets 1 10 .
Caroline B. Madsen, Cecilie Petersen, Kirstine Lavrsen, Mikkel Harndahl, Søren Buus, Henrik Clausen, Anders E. Pedersen & Hans H. Wandall. (2012) Cancer Associated Aberrant Protein O-Glycosylation Can Modify Antigen Processing and Immune Response. PLoS ONE 7:11, pages e50139.
Crossref
Sylvain Julien, Paula A. Videira & Philippe Delannoy. (2012) Sialyl-Tn in Cancer: (How) Did We Miss the Target?. Biomolecules 2:4, pages 435-466.
Crossref
Ravi A. Madan, Marijo Bilusic, Christopher Heery, Jeffrey Schlom & James L. Gulley. (2012) Clinical Evaluation of TRICOM Vector Therapeutic Cancer Vaccines. Seminars in Oncology 39:3, pages 296-304.
Crossref
Mahsa Mohebtash, Kwong-Yok Tsang, Ravi A. Madan, Ngar-Yee Huen, Diane J. Poole, Caroline Jochems, Jacquin Jones, Theresa Ferrara, Christopher R. Heery, Philip M. Arlen, Seth M. Steinberg, Mary Pazdur, Myrna Rauckhorst, Elizabeth C. Jones, William L. Dahut, Jeffrey Schlom & James L. Gulley. (2011) A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer. Clinical Cancer Research 17:22, pages 7164-7173.
Crossref
Cecilia Larocca & Jeffrey Schlom. (2011) Viral Vector-Based Therapeutic Cancer Vaccines. The Cancer Journal 17:5, pages 359-371.
Crossref
Gail Sckisel, Julia Tietze & William Murphy. 2011. Cancer Vaccines. Cancer Vaccines 9 24 .
Gail D. Sckisel, Julia K. Tietze & William J. Murphy. 2011. Cancer Vaccines: From Research to Clinical Practice. Cancer Vaccines: From Research to Clinical Practice 9 24 .
XueQing Lun, Jennifer Chan, Hongyuan Zhou, Beichen Sun, John JP Kelly, Owen Owen Stechishin, John C Bell, Kelley Parato, Kang Hu, Dominique Vaillant, Jiahu Wang, Ta-Chiang Liu, Caroline Breitbach, David Kirn, Donna L Senger & Peter A Forsyth. (2010) Efficacy and Safety/Toxicity Study of Recombinant Vaccinia Virus JX-594 in Two Immunocompetent Animal Models of Glioma. Molecular Therapy 18:11, pages 1927-1936.
Crossref
Seunghee Kim-Schulze, Hong Sung Kim, Alberto Wainstein, Dae Won Kim, Wein Cui Yang, Dorota Moroziewicz, Phyllus Y. Mong, Michal Bereta, Bret Taback, Qin Wang & Howard L. Kaufman. (2008) Intrarectal Vaccination with Recombinant Vaccinia Virus Expressing Carcinoembronic Antigen Induces Mucosal and Systemic Immunity and Prevents Progression of Colorectal Cancer. The Journal of Immunology 181:11, pages 8112-8119.
Crossref
Kerrilyn R. Diener, Erin L. Lousberg, Emma L. Beukema, Anastasia Yu, Paul M. Howley, Michael P. Brown & John D. Hayball. (2008) Recombinant fowlpox virus elicits transient cytotoxic T cell responses due to suboptimal innate recognition and recruitment of T cell help. Vaccine 26:29-30, pages 3566-3573.
Crossref
James L. Gulley, Philip M. Arlen, Kwong-Yok Tsang, Junko Yokokawa, Claudia Palena, Diane J. Poole, Cinzia Remondo, Vittore Cereda, Jacquin L. Jones, Mary P. Pazdur, Jack P. Higgins, James W. Hodge, Seth M. Steinberg, Herbert Kotz, William L. Dahut & Jeffrey Schlom. (2008) Pilot Study of Vaccination with Recombinant CEA-MUC-1-TRICOM Poxviral-Based Vaccines in Patients with Metastatic Carcinoma. Clinical Cancer Research 14:10, pages 3060-3069.
Crossref
Jeffrey Schlom, James L. Gulley & Philip M. Arlen. (2008) Paradigm Shifts in Cancer Vaccine Therapy. Experimental Biology and Medicine 233:5, pages 522-534.
Crossref
J Prieto, V Fernandez-Ruiz, M P Kawa, P Sarobe & C Qian. (2008) Cells as vehicles for therapeutic genes to treat liver diseases. Gene Therapy 15:10, pages 765-771.
Crossref
Mads Agervig Tarp & Henrik Clausen. (2008) Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochimica et Biophysica Acta (BBA) - General Subjects 1780:3, pages 546-563.
Crossref
Pierpaolo Correale, Maria Teresa Del Vecchio, Marco La Placa, Francesco Montagnani, Giuseppa Di Genova, Gianni Gori Savellini, Chiara Terrosi, Susanna Mannucci, Giorgio Giorgi, Guido Francini & Maria Grazia Cusi. (2008) Chemotherapeutic Drugs may be Used to Enhance the Killing Efficacy of Human Tumor Antigen Peptide-specific CTLs. Journal of Immunotherapy 31:2, pages 132-147.
Crossref
Manzoor M. KhanManzoor M. Khan. 2008. Immunopharmacology. Immunopharmacology 227 252 .
Dung Le, Elizabeth M. Jaffee & Dan Laheru. 2008. Pancreatic Cancer. Pancreatic Cancer 683 704 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.